“We believe that our vaccine offers durable protection against COVID-19 and elicits neutralizing activity against the Delta variant,” Paul Stoffels, J&J’s chief scientific officer, said in a statement. “This adds to the robust body of clinical data supporting our single-shot vaccine’s ability to protect against multiple variants of concern.”
The company also said that the immune response produced by the vaccine lasts at least eight months.
“Current data for the eight months studied so far show that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time,” Mathai Mammen of Johnson & Johnson said in a statement.
Source: US News
One in five Americans are unwilling to get vaccinated
A September survey found that nearly one in five Americans are unwilling to get vaccinated.
Source: Morning Consult